Press play button to have the text read to you.
This third edition of the BJMO in 2025 once again covers a wide range of topics across the field of oncology.
In the review section, Dr. Gennigens et al. provide the first part of an overview of the accuracy of emerging therapies in gynaecological cancers with respect to locally advanced and metastatic cervical cancer. The authors highlight the promising potential of new innovative treatments for improving survival outcomes for these patients. A second review provided by Dr. Loizidis and Prof. Ignatiadis outlines the clinical application of circulating tumour DNA in breast cancer management. The authors discuss the current indications for circulating tumour DNA as well as ongoing studies in breast cancer.
In the healthcare section, Dr. Pape highlights the need for more information and support regarding bowel problems after surgical resection for patients who have survived rectal cancer. In a second article in this section, Prof. Meunier advocates for the “Right to be forgotten” for cancer survivors with regard to health-related financial discrimination. This article exemplifies the system used in Belgium as one of the most advanced frameworks to prevent this discrimination.
Lastly in this issue, a congress highlights article from Dr. Lybaert provides an in depth discussion of the highlights of the Gastrointestinal Cancers Symposium along with the clinical relevance of the results of these studies. Dr. Punie et al. provide a second article on the highlights of new data on systemic therapy for breast cancer from the SABCS congress. This article summarises the most important data regarding systemic breast cancer treatment.
We wish you a pleasant read!
The Publisher
Top
